Chengdu NewRT Medical Technology
PrivateLast Round
Series E
Apr 3, 2026
Est. Valuation
$110M
Total Funding Raised
$313.17M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Chengdu NewRT Medical Technology is a biotechnology company that develops and produces medical isotopes and radiopharmaceuticals for the diagnosis and treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chengdu NewRT Medical Technology Comparables
Compare Chengdu NewRT Medical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yantai Dongcheng Pharmaceutical Group Co., Ltd. | 82% | |
| Eli Lilly and Company | 82% | |
| C-Ray Therapeutics | 78% |
Chengdu NewRT Medical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 3, 2026 | ||||
| Series D | Oct 10, 2025 | ||||
| Series C | Mar 14, 2024 | ||||
| Series B | Jul 16, 2019 |
Chengdu NewRT Medical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series E |
| Chengdu Aerotropolis Innovation & Venture Capital | Series D |
| PICC Capital Insurance Asset Management | Series D |
| Xingkong Capital | Series C |
| Hunan Provincial Caixin Industrial Fund Management | Series D |
| Efung Capital | Series E |
| Shenzhen Capital Group | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 399, 4433% of headcount.
- Jul 13, 2026
Open roles increased to 332, 3.8x the trailing average.
Chengdu NewRT Medical Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chengdu NewRT Medical Technology's valuation, stock price, and market status.
Is Chengdu NewRT Medical Technology a public or private company?
Chengdu NewRT Medical Technology is a private company.
What is the current stock price of Chengdu NewRT Medical Technology?
Chengdu NewRT Medical Technology is a private company with no public stock price. No recent secondary market data is available.
How much is Chengdu NewRT Medical Technology worth (valuation)?
Valuation information for Chengdu NewRT Medical Technology is not publicly available.
Can I buy Chengdu NewRT Medical Technology stock?
Chengdu NewRT Medical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chengdu NewRT Medical Technology's last funding round?
Funding round information for Chengdu NewRT Medical Technology is not publicly available.
Who are the main investors in Chengdu NewRT Medical Technology?
Investor information for Chengdu NewRT Medical Technology is not publicly disclosed.
Will Chengdu NewRT Medical Technology IPO soon?
No public IPO plans have been announced for Chengdu NewRT Medical Technology.
How can I track Chengdu NewRT Medical Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chengdu NewRT Medical Technology's secondary market activity and sign up for updates.